Verified Document

NRNP Focused SOAP Note Chapter

NRNP/PRAC & Comprehensive Focused SOAP Psychiatric Evaluation Template

Week (enter week #): (Enter assignment title)

Student Name

College of Nursing-PMHNP, Walden University

NRNP 6665: PMHNP Care Across the Lifespan I

Faculty Name

Assignment Due Date

Subjective:

CC (chief complaint):

The client is a 14-year old white female who is brought by her parents for refusing to eat, leading to generalized weakness, severe weight loss, and amenorrhea for four months. The parents are worried because the client has had a regular 26-28 day menstruation cycle since she began menarche aged 12. They fear that she could be pregnant although three tests carried out at home have all been negative.

HPI

The clients parents report that she has been dieting since seven months prior to the visit and that the condition began when her friends teased her about her greedy appetite and plumpness. As a result, she had stared restricting her food intake, engaging routinely in excessive exercises, and avoiding food high in fat. She frequently misses breakfast and lunch, and during dinner, she secretly puts food in a plastic bag and throws it in the dustbin. The client denies inducing purging or vomiting, but she perceives herself as fat. She is unhappy with her self image and believes that she is not pretty. The client is the oldest of two siblings and describes her parents as overprotective and strict. She feels that her father is excessively controlling and never allows her to make independent decisions. She reports being unable to be her real self as she is forced to live according to her fathers wishes. She admits having difficulty communicating with her younger sister and father, but believes that her mother understands her. Her parents describe her as a perfectionist and a lady obsessed with punctuality and cleanliness. Academically, she is above average and the family history is not indicative of mental illness or eating disorders. A few weeks before the visit, the client experienced epigastric pain that was accompanied by vomiting, joint aches, headaches, and severe fatigue. Her PCP prescribed antiemetics and multivitamins that helped to improve symptoms. The client denies having a boyfriend or involvement in sexual activity.

Substance Current Use:

Medical History:

Current Medications: None

Allergies: No Known Allergies

Reproductive Hx: LMP was four months ago

ROS:

GENERAL: The client denies chills and fever, although clinical tests show low blood pressure (hypotension) and bradycardia. Clinical examination reveals a thin girl with a height of 1.47m, weight of 28kg, and BMI of 13kg/m3, which reflects a 13 percent deficit in weight for her height.

HEENT: Eyes: No Visual Loss, blurred vision, double vision, or yellow sclerae; Ears, Nose and Throat: No hearing loss, sneezing, congestion, runny nose, or sore throat

SKIN: No itching or rash, although skin was generally dry

CARDIOVASCULAR: No chest tightness, palpitations or edema

RESPIRATORY: No shortness of breath, cough or sputum

GASTROINTESTINAL: no stomach cramps, indigestion, constipation, or heartburn

GENITOURINARY: No burning on urination, hesitancy, or odd color

NEUROLOGICAL: Occasional headaches and dizziness, but no change in bladder or bowel control.

MUSCULOSKELETAL: Generalized muscle weakness

HEMATOLOGIC: No signs of bleeding, anemia or bruises

LYMPHATICS: Nodes are of normal size

ENDOCRINOLOGIC: client denies experiencing cold, profuse sweating, or heat intolerance. No polyuria or polydipsia .

Objective:

Diagnostic results:

An electrocardiogram (EKG) test and chest x-rays were ordered to rule out cardiac conditions as potential causes of the clients hypotension (Khairani et al., 2011). The clinician additionally ordered a complete blood count (CBC) to exclude medical conditions such as anemia and hyperthyroidism, which have similar presentations and could also account for amenorrhea and the frequent headaches and dizziness (Khairani et al., 2011). Results of the blood investigation were within normal limits. A urine...

…a lower risk of suicidal thoughts in pediatric patients as compared to other SSRIs (Gordon & Melvin, 2014). At the same time, Olanzapine has been associated with a high risk of orthostatic hypotension, particularly during initial dose titration (FDA 2014). The clients bradycardia poses as a risk factor in this case, necessitating proper clinical monitoring for cardiovascular changes (FDA, 2014). When used as prescribed, however, the combination treatment is expected to correct distorted thoughts about body shape in 4 to 6 weeks (FDA, 2014).

Discussed Risks of Mixing Medication:

The safety of co-administering Olanzapine and Fluoxetine at high dosages above 18mg and 75 mg respectively has not been evaluated in pediatric patients (FDA, 2014). This indicates a need for proper monitoring for adverse effects during maintenance therapy (FDA, 2014).

Client has Emergency Numbers:

The client was advised to contact the healthcare provider or call 911 in case of emergency or if she experiences suicidal thoughts, seizures, or tardive dyskinesia (FDA, 2014).

Time Allowed for Questions and Answers:

Questions were asked throughout the interview as a means of obtaining subjective information and at the end to test the clients understanding.

Follow-Up with PCP:

The role of the PCP is to assist in the management strategies of the treatment team by assessing medical complications and monitoring weight and nutritional status (Khairani et al., 2011). The PCP will assess for the presence of any complications related to hypotension, endocrine abnormalities, seizures, kidney dysfunction, electrolyte imbalance, and amenorrhea (Khairani et al., 2011). Referral to other specialists should be indicated if these complications occur (Khairani et al., 2011). .

Labs Ordered or Reviewed:

Undesirable alterations in lipids have been observed with the use of Olanzapine and the FDA recommends appropriate clinical monitoring of fasting lipids (FDA, 2014). Fasting blood sugar tests were thus ordered to obtain baseline levels before treatment commenced.

Return to Clinic: Client to return…

Sources used in this document:

References

APA (2013). Diagnostic and Statistical Manual of Mental Disorders (5 th ed.). Washington, DC: American Psychitaric Association.

Food and Drug Administration (FDA). Prozac: Highlighs of Prescribing Information. US Food and Drug Administration (FDA). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s108lbl.pdf

Gordon, M. S., & Melvin, G. (2014). Do Antidepressants make Chilren and Adolescents Suicidal? Journal of Pediatrics and Child Health, 50(11), 847-54.

Khairani, O., Majmin. S., Saharuddin, A., Loh, S., & Tohid, H. (2011). An Adolescent with Anorexia Nervosa: A Case Study. Malaysian Family Physician, 6(2), 79-81.

Resmark, G., Herpetz, S., Dahlmann, B., & Zeeck, A.(2018). Treatment of Anorexia Nervosa- New Evidence-Based Guidelines. Journal of Clinical Medicine,8(2), 153-170.

Yan, C., Kao, L.,…& Yeh, M. (2019). Healthcare Utilization for Eating Disorders among Patiens in Taiwan: A Coss-Sectional Study in Taiwan. BMJ Open, 9(12), doi: 10.1136/bmjopen-2019-032108Ziser, K., Rheindorf, N., Keifenheim, K., …& Junne, F. (2021). Motivation-Enhancing Psychotherapy for Inpatients with Anorexia Nervosa – A Randomized Controlled Pilot Study. Frontiers in Psychiatry, doi: org/10.3389/fpsyt.2021.632660© 2021 Walden University Page 11 of 11

Cite this Document:
Copy Bibliography Citation

Related Documents

FDA: Center for Drug Evaluation and Research
Words: 1105 Length: 3 Document Type: Essay

FDA: Center for Drug Evaluation and Research (CDER) And Over-the-counter Weight Loss Medications Obesity is one of the most serious epidemics facing the American public. "Over two-thirds of adults in the United States are overweight or obese, and over one-third are obese" (Overweight and obesity statistics, 2012, WIN). To address concerns about obesity, many adults turn to over-the-counter medications like dietary supplements that promise the user easy weight loss. The medications usually

FDA Classification the FDA Is
Words: 577 Length: 2 Document Type: Term Paper

Given that there is no expectation of substantial equivalence, the following process will need to be undertaken. The 510(K) that needs to be submitted is the Traditional. A Special is for modifications to products that already have 510(k) approval, so that does not apply in this case. An Abbreviated 510(K) applies when a product is approved for this process by the FDA. There is little explanation on the FDA website

FDA Health Policy on Intravesical
Words: 3065 Length: 10 Document Type: Research Paper

Phase II consists of efficacy trials of the drug, which are tested on volunteers of the target population. When everything goes right, the drug manufacturer discusses the development process, continued human testing, other concerns and protocols for phase III with the FDA. Phase III is the more extensive. It is at this time that the manufacture can work for the accelerated development and review of the drug. Treatment IND

FDA and Gene Therapy
Words: 892 Length: 2 Document Type: Term Paper

Gene Therapy FDA Ethics can be considered to come from personal values. From both a medical and a business perspective, ethics are the reasons that some news stories should be followed from beginning to end and all in between. "On Sunday morning, 23 February 1997, the world awoke to a technological advance that shook the foundations of biology and philosophy. On that day, we were introduced to Dolly, a 6-month-old lamb that

FDA Homeopathics
Words: 748 Length: 2 Document Type: Essay

Divisions of the FDA The FDA is in charge of the regulation of pharmaceutical drugs and medical devices, as part of its mandate to safeguard the U.S. health care system. One unit for this is the Center for Devices and Radiological Health (CDRH), which approves medical devices. The unit that approves drugs is the Center for Drug Evaluation and Research (CDER). There is also the Center for Biologics Evaluation and Research

FDA and Its Regulatory Powers
Words: 1619 Length: 4 Document Type: Essay

Administrative Law REGULATING STEM CELL THERAPY Administrative Agency: Food and Drug Administration Article 1 Section 1 of the federal Constitution creates administrative agencies, which are law-making entities but with limited powers (USLegal, 2014). The rules and regulations created by an administrative agency are lawfully enforceable. It assists in the faster management of cases and is, therefore, a big help to U.S. courts. The administrative process is also a valuable resource for other important

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now